Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Restructuring charges — Exit & other costs by Year
Restructuring charges — Exit & other costs ($M) ($M)
Pfizer Restructuring charges — Exit & other costs: $59M in FY2025, down 85.4% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Note 3 — Restructuring Charges & Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring charges — Exit & other costs ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59 | -85.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 403 | +238.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 119 | +120.4% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 54 | +575.0% | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 8 | -233.3% | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | -6 | -112.0% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 50 | +51.5% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 33 | +57.1% | Form 10-K (filed 2020-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 21 | -71.6% | Form 10-K (filed 2019-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 74 | +8.8% | Form 10-K (filed 2018-02-22) ↗ |
| FY2015 | Dec 31, 2015 | 68 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Pfizer Restructuring charges — Exit & other costs ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/restruct-chg-exit
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.